Revisión y caso clínico | 08 AGO 20

Rinosinusitis crónica con pólipos nasales

Diagnóstico y manejo de los pólipos nasales en el contexto de rinosinusitis crónica
Autor/a: Claire Hopkins N Engl J Med 2019; 381:55-63.
INDICE:  1. Texto principal | 2. Referencias bibliográficas
Referencias bibliográficas

1. Fokkens WJ, Lund VJ, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl 2012; 23: 1-298.

2. Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg 1995; 113: 104-9.

3. Abdalla S, Alreefy H, Hopkins C. Prevalence of Sinonasal Outcome Test (SNOT-22) symptoms in patients undergoing surgery for chronic rhinosinusitis in the England and Wales National prospective audit. Clin Otolaryngol 2012; 37: 276-82.

4. Hox V, Bobic S, Callebaux I, Jorissen M, Hellings PW. Nasal obstruction and smell impairment in nasal polyp disease: correlation between objective and subjective parameters. Rhinology 2010; 48: 426-32.

5. Larsen K, Tos M. The estimated incidence of symptomatic nasal polyps. Acta Otolaryngol 2002; 122: 179-82.

6. Johansson L, Akerlund A, Holmberg K, Melén I, Bende M. Prevalence of nasal polyps in adults: the Skövde populationbased study. Ann Otol Rhinol Laryngol 2003; 112: 625-9.

7. Settipane GA, Chafee FH. Nasal polyps in asthma and rhinitis: a review of 6,037 patients. J Allergy Clin Immunol 1977; 59:17-21.

8. Woodard T, Sindwani R, Halderman AA, Holy CE, Gurrola J II. Variation in delivery of sinus surgery in the Medicaid population across ethnicities. Otolaryngol Head Neck Surg 2016; 154: 944-50.

9. Kim JE, Kountakis SE. The prevalence of Samter’s triad in patients undergoing functional endoscopic sinus surgery. Ear Nose Throat J 2007; 86: 396-9.

10. Marple BF. Allergic fungal rhinosinusitis: current theories and management strategies. Laryngoscope 2001; 111:1006-19.

11. Del Gaudio JM, Loftus PA, Hamizan AW, Harvey RJ, Wise SK. Central compartment atopic disease. Am J Rhinol Allergy 2017; 31: 228-34.

12. Van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006; 61: 1280-9.

13. Tomassen P, Vandeplas G, Van Zele T, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol 2016; 137(5): 1449-1456.e4.

14. Ragab A, Clement P, Vincken W. Objective assessment of lower airway involvement in chronic rhinosinusitis. Am J Rhinol 2004; 18: 15-21.

15. Promsopa C, Kansara S, Citardi MJ, Fakhri S, Porter P, Luong A. Prevalence of confirmed asthma varies in chronic rhinosinusitis subtypes. Int Forum Allergy Rhinol 2016; 6: 373-7.

16. Grigoreas C, Vourdas D, Petalas K, Simeonidis G, Demeroutis I, Tsioulos T. Nasal polyps in patients with rhinitis and asthma. Allergy Asthma Proc 2002; 23: 169-74.

17. Beule A. Epidemiology of chronic rhinosinusitis, selected risk factors, comorbidities, and economic burden. GMS Curr Top Otorhinolaryngol Head Neck Surg 2015; 14: Doc11.

18. Cohen NA, Widelitz JS, Chiu AG, Palmer JN, Kennedy DW. Familial aggregation of sinonasal polyps correlates with severity of disease. Otolaryngol Head Neck Surg 2006; 134: 601-4.

19. Veloso-Teles R, Cerejeira R, Roque-Farinha R, von Buchwald C. Higher preva-lence of nasal polyposis among textile workers: an endoscopic based and controlled study. Rhinology 2018; 56: 99-105.

20. De Schryver E, Derycke L, Campo P, et al. Alcohol hyper-responsiveness in chronic rhinosinusitis with nasal polyps. Clin Exp Allergy 2017; 47: 245-53.

21. Naclerio RM, Bachert C, Baraniuk JN. Pathophysiology of nasal congestion. Int J Gen Med 2010; 3: 47-57.

22. Kim JK, Cho JH, Jang HJ, Shim DB, Shin HA. The effect of allergen provocation on the nasal cycle estimated by acoustic rhinometry. Acta Otolaryngol 2006; 126: 390-5.

23. Stanton AE, McGarry GW, Carter R, Bucknall CE. Spectrum of nasal disease in an asthma clinic: when is an ENT opinion indicated? J Laryngol Otol 2009; 123: 613-8.

24. Lund VJ, Clarke PM, Swift AC, McGarry GW, Kerawala C, Carnell D. Nose and paranasal sinus tumours: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol 2016; 130: S2: S111-S118.

25. Tosun F, Arslan HH, Karslioglu Y, Deveci MS, Durmaz A. Relationship between postoperative recurrence rate and eosinophil density of nasal polyps. Ann Otol Rhinol Laryngol 2010; 119: 455-9.

26. Orlandi RR, Kingdom TT, Hwang PH, et al. International consensus statement on allergy and rhinology: rhinosinusitis.

Int Forum Allergy Rhinol 2016; 6: Suppl 1: S22-S209.

27. Rudmik L, Hopkins C, Peters A, Smith TL, Schlosser RJ, Soler ZM. Patientreported outcome measures for adult chronic rhinosinusitis: a systematic review and quality assessment. J Allergy Clin Immunol 2015; 136(6): 1532-1540.e2.

28. Hopkins C, Hettige R, Soni-Jaiswal A, et al. Chronic Rhinosinusitis Outcome MEasures (CHROME), developing a core outcome set for trials of interventions in chronic rhinosinusitis. Rhinology 2018; 56: 22-32.

29. Doulaptsi M, Prokopakis E, Seys S, Pugin B, Steelant B, Hellings P. Visual analogue scale for sino-nasal symptoms severity correlates with Sino-Nasal Outcome Test 22: paving the way for a simple outcome tool of CRS burden. Clin Transl

Allergy 2018; 8: 32.

30. Chong LY, Head K, Hopkins C, Philpott C, Burton MJ, Schilder AG. Different types of intranasal steroids for chronic rhinosinusitis. Cochrane Database Syst Rev 2016; 4: CD011993.

31. Sastre J, Mosges R. Local and systemic safety of intranasal corticosteroids. J Investig Allergol Clin Immunol 2012; 22: 1-12.

32. Rudmik L, Xu Y, Liu M, Bird C, Kukec E, Quan H. Utilization patterns of topical intranasal steroid therapy for chronic rhinosinusitis: a Canadian population-based analysis. JAMA Otolaryngol Head Neck Surg 2016; 142: 1056-62.

33. Kalish L, Snidvongs K, Sivasubramaniam R, Cope D, Harvey RJ. Topical steroids for nasal polyps. Cochrane Database Syst Rev 2012; 12: CD006549.

34. Harvey RJ, Snidvongs K, Kalish LH, Oakley GM, Sacks R. Corticosteroid nasal irrigations are more effective than simple sprays in a randomized double-blinded placebo-controlled trial for chronic rhinosinusitis after sinus surgery. Int Forum Allergy Rhinol 2018; 8: 461-70.

35. Head K, Chong LY, Hopkins C, Philpott C, Burton MJ, Schilder AG. Shortcourse oral steroids alone for chronic rhinosinusitis. Cochrane Database Syst Rev 2016; 4: CD011991.

36. Ou J, Wang J, Xu Y, et al. Staphylococcus aureus superantigens are associated with chronic rhinosinusitis with nasal polyps: a meta-analysis. Eur Arch Otorhinolaryngol 2014; 271: 2729-36.

37. Van Zele T, Gevaert P, Holtappels G, et al. Oral steroids and doxycycline: two different

approaches to treat nasal polyps. J Allergy Clin Immunol 2010; 125(5): 1069-1076.e4.

38. Varvyanskaya A, Lopatin A. Efficacy of long-term low-dose macrolide therapy in preventing early recurrence of nasal polyps after endoscopic sinus surgery. Int Forum Allergy Rhinol 2014; 4: 533-41.

39. Sacks PL, Harvey RJ, Rimmer J, Gallagher RM, Sacks R. Topical and systemic antifungal therapy for the symptomatic treatment of chronic rhinosinusitis. Cochrane Database Syst Rev 2011; 8: CD008263.

40. Rudmik L, Soler ZM, Hopkins C, et al. Defining appropriateness criteria for endoscopic sinus surgery during management of uncomplicated adult chronic rhinosinusitis: a RAND/UCLA appropriateness study. Rhinology 2016; 54: 117-28.

41. Kilty SJ, Lasso A, Mfuna-Endam L, Desrosiers MY. Case-control study of endoscopic polypectomy in clinic (EPIC) versus endoscopic sinus surgery for chronic rhinosinusitis with polyps. Rhinology 2018; 56: 155-7.

42. Hopkins C, Slack R, Lund V, Brown P, Copley L, Browne J. Long-term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis. Laryngoscope 2009; 119: 2459-65.

43. DeConde AS, Mace JC, Levy JM, Rudmik L, Alt JA, Smith TL. Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis. Laryngoscope 2017; 127:550-5.

44. Rowe-Jones JM, Medcalf M, Durham SR, Richards DH, Mackay IS. Functional endoscopic sinus surgery: 5 year follow up and results of a prospective, randomised, stratified, double-blind, placebo controlled study of postoperative fluticasone propionate aqueous nasal spray. Rhinology 2005; 43: 2-10.

45. Klimek L, Dollner R, Pfaar O, Mullol J. Aspirin desensitization: useful treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in aspirin-exacerbated respiratory disease (AERD)? Curr Allergy Asthma Rep 2014; 14: 441.

46. Levy JM, Smith TL. Is aspirin desensitization indicated for the treatment recalcitrant chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease? Laryngoscope 2017; 127: 776-7.

47. Leopold DA, Elkayam D, Messina JC, Kosik-Gonzalez C, Djupesland PG, Mahmoud RA. NAVIGATE II: randomized, double- blind trial of the exhalation delivery system with fluticasone for nasal polyposis. J Allergy Clin Immunol 2019; 143(1): 126-134.e5.

48. Kern RC, Stolovitzky JP, Silvers SL, et al. A phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps. Int Forum Allergy Rhinol 2018; 8: 471-81.

49. Gevaert P, Calus L, Van Zele T, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol 2013; 131(1): 110-6.e1.

50. Gevaert P, Van Bruaene N, Cattaert T, et al. Mepolizumab, a humanized anti- IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol 2011; 128(5): 989-95.e1.

51. Bachert C, Mannent L, Naclerio RM, et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. JAMA 2016; 315: 469-79.

52. Small CB, Hernandez J, Reyes A, et al. Efficacy and safety of mometasone furoate nasal spray in nasal polyposis. J Allergy Clin Immunol 2005; 116: 1275-81.

53. Bachert C, Akdis CA. Phenotypes and emerging endotypes of chronic rhinosinusitis. J Allergy Clin Immunol Pract 2016; 4: 621-8.




Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí

Contenidos relacionados
Los editores le recomiendan continuar con las siguientes lecturas:
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2020